Arcuro Medical

Arcuro Medical is developing an all-suture, “all-inside” meniscus repair system.

The Product & Advantages

Arcuro Medical’s novel approach is based on a technique in which the entire procedure is performed inside the joint space using suture material only and requiring just one entry into the joint. Arcuro’s proprietary SuperBall repair system consists of a knotless all-suture anchor and innovative delivery system for a meniscus repair that is secure, safe, reliable, and effective.

  • Preserves meniscus functionality
  • Repairs hard to reach areas and provides full meniscus coverage
  • Is easy to operate

The Team


Arcuro Medical’s CEO Lee Ranon (standing) and CTO Ran Oren discuss the Company’s novel meniscus repair system.

  • Lee Ranon, CEO: Extensive managerial and business development experience; previous positions include marketing and sales director at T.A.G. Medical Products, operations and project development manager at T.A.G., and European marketing and sales manager at Frutarom Industries; worldwide connections with key opinion leaders in the international sports medicine and orthopedics communities
  • Ran Oren, CTO: Over 20 years’ experience in the medical device industry; founder, CEO & R&D director at T.A.G. Medical Products, products developed at T.A.G. are currently sold worldwide by J&J, Stryker, S&N, Tornier, and others; invented, developed, and commercialized numerous innovative medical devices; written 35 international patents
  • Elad Rash, Development Engineer: 7 years’ experience as development engineer T.A.G. Medical Products, specialty in medical devices for sports medicine

The Advisory Board

  • Preston Wolin, MD: Director of Sports Medicine, Louis A. Weiss Memorial Hospital, Center for Athletic Medicine, Chicago, Illinois
  • Rob Meislin, MD: Assistant Professor, Departments of Orthopaedic Surgery (Ortho-Research) and Hospital for Joint Diseases, New York University Orthopedic Surgery Associates
  • Ron Arbel, MD: Head of Sports Department, Orthopedic Surgery, Tel Aviv Sourasky Medical Center
  • Stuart Fromm, MD: Black Hills Orthopedic & Spine Center, Rapid City, South Dakota

Trendlines’ directors: Todd Dollinger, Barak Singer


Founded: December 2013
 Business development
Investors: The Trendlines Group, Naton Medical Group
IP: National phase (United States, Europe, Israel, China)


  • June 2018: FDA regulatory clearance
  • May 2018: U.S. patent
  • EN/ISO 13485:2012
  • Q3 2017: FDA submission
  • Successful cadaver studies

Background & Market

Located in the knee joint, the delicate meniscus is a C-shaped cartilage that acts as a shock absorber and “cushions” the knee. Meniscus tears can be found in professional athletes, and as much as 60% of the population over age 65.

To maintain functionality, current practice is moving away from surgical removal of the meniscus toward arthroscopic repair techniques. Shortcomings of current repair devices, however, include rigid implants and difficult-to-use delivery systems that lead to poor repair quality, increased intraoperative failure, long-term damage to the meniscus, device failures, and the inability to repair all areas of the meniscus.

Worldwide, there are more than 2 million meniscus procedures performed annually. The global market (excluding China) is $300 million, with a CAGR of 13%.

Among the leading players: Arthex, ConMed, DePuy Synthes, Smith & Nephew, Zimmer.



Watch the product animation.

See the company 1-page description in Chinese (PDF).

Watch the product animation (Chinese).


Lee Ranon, CEO




Arcuro logo

Font Resize